InvestorsObserver
×
News Home

Does AVEO Pharmaceuticals, Inc. (AVEO) Have What it Takes to be in Your Portfolio Thursday?

Thursday, May 26, 2022 01:42 PM | InvestorsObserver Analysts

Mentioned in this article

Does AVEO Pharmaceuticals, Inc. (AVEO) Have What it Takes to be in Your Portfolio Thursday?

AVEO Pharmaceuticals, Inc. (AVEO) is near the top in its industry group according to InvestorsObserver. AVEO gets an overall rating of 58. That means it scores higher than 58 percent of stocks. AVEO Pharmaceuticals, Inc. gets a 80 rank in the Biotechnology industry. Biotechnology is number 75 out of 148 industries.

Overall Score - 58
AVEO has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on AVEO!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 58 would rank higher than 58 percent of all stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With AVEO Pharmaceuticals, Inc. Stock Today?

AVEO Pharmaceuticals, Inc. (AVEO) stock is trading at $4.33 as of 1:38 PM on Thursday, May 26, a rise of $0.44, or 11.31% from the previous closing price of $3.89. The stock has traded between $3.85 and $4.34 so far today. Volume today is below average. So far 112,280 shares have traded compared to average volume of 201,025 shares. Click Here to get the full Stock Report for AVEO Pharmaceuticals, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App